C030030A07Rik Inhibitors
C030030A07Rik, found in the RIKEN cDNA C030030A07 gene, plays a crucial role in cellular processes, potentially involving gene expression regulation. While direct inhibitors for C030030A07Rik remain unidentified, exploration into potential inhibitors targeting key signaling pathways provides a foundation for future investigations. The PI3K-AKT, MAPK/ERK, TGF-β, and JNK pathways emerge as pivotal players influencing C030030A07Rik. These pathways collectively contribute to cellular responses and gene expression dynamics associated with this protein.
The function of C030030A07Rik is intricately tied to these pathways, where PI3K-AKT regulates cellular survival and proliferation, MAPK/ERK controls cell growth and differentiation, TGF-β influences cellular homeostasis, and JNK pathway modulates stress responses. The intricate interplay of C030030A07Rik with these signaling cascades necessitates further investigation to unveil the specific mechanisms governing its function and potential avenues for modulation. Understanding these pathways and their interactions with C030030A07Rik will pave the way for targeted interventions, shedding light on the regulatory intricacies of this enigmatic protein.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a phosphoinositide 3-kinase (PI3K) inhibitor. Its disruption of the PI3K-AKT pathway is anticipated to influence cellular processes linked to C030030A07Rik, potentially altering the landscape of gene expression and regulatory mechanisms associated with this protein. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 serves as a p38 MAP kinase inhibitor. Its modulation of the MAPK pathway, particularly p38 MAP kinase, may indirectly affect C030030A07Rik by altering the dynamics of cellular responses crucial for this enigmatic protein. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin is envisaged to indirectly impact C030030A07Rik by modulating mTOR-dependent cellular processes. This modulation could potentially alter the landscape of gene expression and the regulatory mechanisms associated with C030030A07Rik. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 may indirectly influence C030030A07Rik by suppressing c-Jun N-terminal kinase activity. This suppression could impact gene expression dynamics associated with C030030A07Rik by altering cellular stress responses. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 is envisaged to impact C030030A07Rik by altering the MAPK/ERK pathway. Its inhibition of MEK1 could potentially influence the regulatory mechanisms of this protein, leading to alterations in gene expression dynamics. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
SB431542, acting as a selective inhibitor of the TGF-β type I receptor ALK5 may indirectly impact C030030A07Rik by altering the signaling cascade related to the TGF-β pathway. This modulation could potentially influence the regulatory mechanisms associated with C030030A07Rik, affecting gene expression dynamics. | ||||||
AZD5363 | 1143532-39-1 | sc-503190 | 5 mg | $309.00 | ||
AZD5363 is an AKT kinase inhibitor. Its modulation of the PI3K-AKT pathway is anticipated to intricately influence cellular processes linked to C030030A07Rik, potentially altering the dynamics of gene expression and regulatory mechanisms associated with this protein. | ||||||
VX 745 | 209410-46-8 | sc-361401 sc-361401A | 10 mg 50 mg | $183.00 $842.00 | 4 | |
VX-745 is an envisioned JAK2 inhibitor that targets the JAK-STAT pathway. The speculative influence of VX-745 on C030030A07Rik centers around its capacity to impact downstream STAT signaling, potentially altering the cellular responses linked to the protein's regulatory mechanisms. | ||||||
SB 202190 | 152121-30-7 | sc-202334 sc-202334A sc-202334B | 1 mg 5 mg 25 mg | $30.00 $125.00 $445.00 | 45 | |
SB202190, acting as a p38 MAP kinase inhibitor may indirectly influence C030030A07Rik by disrupting p38 MAP kinase activity. The disruption of this kinase, a key regulator implicated in gene expression dynamics, could impact the regulatory mechanisms of C030030A07Rik. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin, is a phosphoinositide 3-kinase (PI3K) inhibitor. Its disruption of the PI3K-AKT pathway is anticipated to influence cellular processes linked to C030030A07Rik, potentially altering the landscape of gene expression and regulatory mechanisms associated with this protein. | ||||||